Ontario s Paediatric Referral and Listing Criteria for Small Bowel and Liver- Small Bowel Transplantation

Similar documents
Ontario s Referral and Listing Criteria for Adult Kidney Transplantation

Ontario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation

Ontario s Adult Referral and Listing Criteria for Liver Transplantation

Ontario s Referral and Listing Criteria for Adult Heart Transplantation

Ontario s Referral and Listing Criteria for Adult Lung Transplantation

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

ESPEN Congress Brussels 2005 INDICATIONS FOR INTESTINAL TRANSPLANTATION. Loris Pironi

Policy Specific Section: May 16, 1984 April 9, 2014

Staging & Current treatment of HCC

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United

Corporate Medical Policy

Decramer 2014 a &b [21]

HEALTH SERVICES POLICY & PROCEDURE MANUAL

2. To provide an ethical, moral and practical framework for decision-making during a public health emergency.

Heart/Lung Transplant. Populations Interventions Comparators Outcomes Individuals: With end-stage cardiac and pulmonary disease.

OPEN ACCESS TEXTBOOK OF GENERAL SURGERY

Supplementary Appendix

Candidates about. Lung Allocation Policy. for Transplant. Questions & A n s we r s TA L K I N G A B O U T T R A N S P L A N TAT I O N

Who and When to Refer for a Heart Transplant

Original Policy Date

Evaluation Process for Liver Transplant Candidates

This appendix was part of the submitted manuscript and has been peer. Pre-existing cardiovascular disease was defined by the presence of any of the

Colorectal non-inflammatory emergencies

Pulmonary Hypertension Perioperative Management

Evaluation Process for Liver Transplant Candidates

InterQual Level of Care 2018 Index

UCLA General Surgery Residency Program Rotation Educational Policy Goals and Objectives ROTATION: SURGICAL CRITICAL CARE AND TRANSPLANTATION SURGERY

BTS Guideline for Home Oxygen use in adults Appendix 9 (online only) Key Questions - PICO 10 December 2012

Extracorporeal Life Support (ECLS) as a Bridge to Decision in Lung Transplantation

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives

AORTIC GRAFT INFECTION

Small bowel and Multivisceral Transplantation

Fariba Rezaeetalab Associate Professor,Pulmonologist

Liver Transplantation Evaluation: Objectives

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology

PATIENT SELECTION FOR DECEASED DONOR KIDNEY ONLY TRANSPLANTATION

Student Outline. Improving Transportation Safety: Commercial Driver Medical Examiner Training CHAPTER 1. General FMCSA Information

National Emergency Laparotomy Audit. Help Box Text

Access to Heart and Lung Transplantation for Minority Populations. Cedric Sheffield, MD

WHEN To Initiate Parenteral Nutrition A Frequent Question With New Answers

Chapter 4 Section Small Intestine (SI), Combined Small Intestine-Liver (SI/L), And Multivisceral Transplantation

The Value of Stress MRI in Evaluation of Myocardial Ischemia

Plattenepithelkarzinom des Ösophagus, 1 st -line

Colon ischemia. ACG Clinical Guideline; Am J Gastroenterol 2015

SA XXXX Special Authority for Subsidy

9 Diabetes care. Back to contents

Approach to type 2 Respiratory Failure

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

PRE Operative Care of the High Risk Surgical Patient. Dr A T Dewhurst Consultant Anaesthetist St George s Hospital London

ICU Referral For Common Medical Disorders. Prof. M A Jalil Chowdhury

PARENTERAL NUTRITION- ASSOCIATED LIVER DISEASE IN CHILDREN

2018 Diagnosis Coding Fact Sheet

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not

Clinical Policy: Heart-Lung Transplant Reference Number: CP.MP.132

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders

CCR Keywords Primary keywords

* PLACE OF SERVICE REQUIREMENTS FOR ADDITIONAL HIGHMARK WV MEDICAL POLICIES ANNOUNCED IN THE FEBRUARY 2011 ISSUE OF PROVIDER NEWS *

Aquila Smoldering Multiple Myeloma

Preoperative tests (update)

Critical care resources are often provided to the too well and as well as. to the too sick. The former include the patients admitted to an ICU

HQO s Episode of Care for Chronic Obstructive Pulmonary Disease

Interventional procedures guidance Published: 20 December 2017 nice.org.uk/guidance/ipg600

Contents. Contributors. Reviewers. Acknowledgements I CARDIOVASCULAR COMPLICATIONS

TACO CASE STUDIES RTC JUNE Kerry Dowling Blood Transfusion Laboratory Manager Jonathan Ricks Blood Transfusion Nurse Practitioner

Pulmonary Embolism Pathway

Surviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview

Staging Sepsis for the Emergency Department: Physician

Referring for specialist respiratory input. Dr Melissa Heightman Consultant respiratory physician, UCLH,WH, CNWL

Alliance A Symptomatic brain radionecrosis after receiving radiosurgery for

Index. Note: Page numbers of article titles are in boldface type

ACUTE HEART FAILURE. Julie Gorchynski MD, MSc, FACEP, FAAEM. Department of Emergency Medicine Emergency Residency Program UTHSC, San Antonio TCEP 2014

2017 ACCP/SCCM Critical Care Preparatory Review and Recertification Course Learning Objectives

Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme

Referral for Heart Transplantation - who and when?

AORTIC DISSECTION. DISSECTING ANEURYSMS OF THE AORTA or CLASSIFICATION

Covered Critical Illness Conditions Appendix

Proprietary Acute Care Indicators

Chapter 4 Section 24.1

COMPREHENSIVE RESPIROMETRY

POLICIES AND PROCEDURE MANUAL

Extracorporeal Membrane Oxygenation (ECMO) Referrals

Oxygen Use in Palliative Care Guideline and Flowchart

Information for patients (and their families) waiting for liver transplantation

List of Topics and Modules (2012)

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACTIVASE (t-pa) INFUSION PROTOCOL FOR ACUTE MYOCARDIAL INFARCTION

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Evaluation of Kidney Transplant Recipients

Dr Yuen Wai-Cheung HA Convention 2011

Quality Care Innovation lead clinician for integrated respiratory service georges ng* man kwong

Appendix 1: Supplementary tables [posted as supplied by author]

Platelet aggregation inhibitor. Cardiac chest pain or suspected Myocardial Infarction.

SOUND HEALTH & WELLNESS TRUST

CEDR 2018 QCDR Measures for CMS 2018 MIPS Performance Year Reporting

Cystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012

CHRONIC CAD DIAGNOSIS

Objectives. Nebraska Organ Recovery 2/16/2015. The Role of Hospice and Palliative Care in Organ and Tissue Donation

Transcription:

Ontario s Paediatric Referral and Listing Criteria for Small Bowel and Liver- Small Bowel Transplantation Version 3.0 Trillium Gift of Life Network

Ontario s Paediatric Referral and Listing Criteria for Small Bowel and Liver-Small Bowel Transplantation PATIENT REFERRAL CRITERIA: The patient referral criteria are criteria for which a Health Care Provider would utilize to refer a patient to a transplant centre for assessment. The criteria identified below are the agreed upon conditions for which a paediatric patient should be referred for intestine transplant assessment. Patients with intestinal failure and one of the following should be referred for assessment for intestine or liver-intestine transplantation 1) Hyperbilirubinemia: Referral for intestine transplant assessment should be considered for patients with persistent hyperbilirubinemia (>80 mmol/l) for a period of more than 2 weeks that is not associated with sepsis. 2) Thrombosis: Patients with thrombosis of 2 of 4 upper body central veins or extensive mesenteric venous thrombosis should be referred for transplant assessment. 3) Resection: Referral for small bowel transplant assessment should be considered for children with massive small bowel resection (>75% of small bowel). 4) Disease: Referral for intestine transplant assessment should be considered for patients with microvillous inclusion disease, intestinal epithelial dysplasia and other congenital diarrheas with high mortality risk. 5) Unmanageable Co-morbidities: Children with severely diseased bowel and unmanageable comorbidities including recurrent septic episodes should be referred for transplant assessment. 6) Diagnostic Uncertainty: Patients with continuing prognostic or diagnostic uncertainty should be referred for transplant assessment. 7) Consent: Patients or family members may request a referral for transplant assessment. PATIENT LISTING INDICATIONS: Each patient is assessed individually for their suitability for transplantation by the transplant program. The criteria identified below are the agreed upon conditions for which a paediatric patient may be eligible to be waitlisted for intestine transplantation in Ontario. Paediatric listing criteria pertains to those patients < 18 years (up to but not including their 18th birthday). 1) Intestinal Failure Associated Liver Disease: Listing for transplant may be considered for patients with progressive intestinal failure associated liver disease with persistent elevation of conjugated bilirubin >75mmol/l or/and signs of portal hypertension, or synthetic liver dysfunction with coagulopathy. The liver disease should be refractory to lipid management strategy (fish oil based emulsion or lipid minimization) that was given for at least 6 weeks. 2

2) Vascular Access: Listing for transplant may be considered for patients with loss of 3 standard central venous access sites. 3) Surgical Disasters: Patients with intractable, severe, abdominal fistulae with poor quality of life are eligible to be waitlisted for transplantation. Listing for transplant may also be considered for patients with extensive mesenteric venous thrombosis. 4) Extensive Local Tumours: Patients with otherwise unresectable tumors with no or low grade malignant potential (desmoids tumors, lypmhangiomatosis) are eligible to be waitlisted for transplantation. 5) Quality of life: Listing for transplant may also be considered for patients with intestinal failure with high morbidity and extremely poor quality of life. Listing based on this indication is appropriate for a carefully selected group of patients. 6) ICU Admissions: 2 admissions beyond the NICU period (and not part of the perioperative period), and that require ventilator support or infusion of inotropes should be considered for listing. PATIENT LISTING CONTRAINDICATIONS: The contraindications for transplantation identified below are the agreed upon criteria for which a paediatric patient would not eligible to be waitlisted for intestine transplantation in Ontario. 1) Co-Morbidities: Patients with any co-morbidity that decreases the likelihood of surviving 5 years post-transplant to below 50% or whom which the peri-operative risk is deemed unacceptably high, are not candidates for intestine transplantation. 2) Consent: Patients who do not want a transplant should not be listed for intestine transplantation. 3) Post-Transplant Care: Patients with an inadequate or unsafe post-transplant care plan are not candidates for intestine transplantation. 4) Psychosocial Considerations: Patient non-adherence to therapy is a contraindication to intestine transplantation. Intestine transplantation should be delayed until patients have demonstrated adherence to therapy (compliance with medications) for at least 6 months. 5) Malignancy: Patients with active malignancy are not candidates for transplantation. In general, patients with a previous history of malignancy must be tumour free before proceeding with transplantation. Most transplant candidates should wait a period of time between successful treatment and transplantation. 6) Pulmonary Disease: Patients with the following respiratory conditions and severity are not candidates for intestine transplantation: o Requirement for home oxygen therapy (Grade C); o Uncontrolled asthma (Grade C); o Severe corpulmonale; o Severe chronic obstructive pulmonary disease (COPD), pulmonary fibrosis or restrictive disease with any of the following parameters: Best forced expiratory volume in 1 s (FEV 1) < 25% predicted value; 3

PO 2 room air < 60 mmhg with exercise desaturation, SaO 2 < 90%; > 4 lower respiratory infections in the last 12 months; Moderate disease with evidence of progression. 7) Cardiac Disease: Patients with inoperable valve disease should not be considered for transplant. Patients with severe irreversible (non-uremic) cardiac dysfunction should not be listed for intestinal transplantation alone. Selected patients may be candidates for combined heart intestinal transplants. All patients should be assessed for the presence of ischemic heart disease (IHD) before intestine transplantation. The minimum required investigations include history, physical examination, electrocardiogram (ECG) and a chest radiograph. Intestine transplantation is contraindicated in patients with IHD in the following situations: o Patients with progressive symptoms of angina; o Patients with a myocardial infarction within 6 months; o Patients without an appropriate cardiac workup; o Patients with severe diffuse disease, especially with positive non-invasive tests in whom intervention is not possible and in whom expected survival is sufficiently compromised so that transplantation is not reasonable. 8) Peripheral Vascular Disease: Patients with large uncorrectable abdominal aneurysms, severe occlusive common iliac disease, active gangrene or recent atheroembolic events are not candidates for intestine transplantation. 4

Version Control: Name of Document Ontario s Paediatric Referral and Listing Criteria for Small Bowel and Liver-Small Bowel Transplantation Version 1.0 Created November 2012 Version 2.0 Updated July 2015 Version 3.0 Updated November 2017 Recommended Next Review November 2019 Approved By Provincial Liver and Small Bowel Working Group Transplant Steering Committee 5